Matches 1 - 34 out of 34


Match Document Document Title
US20100297228 UNIVERSAL COATING FOR IMPRINTING IDENTIFICATION FEATURES  
To improve anticounterfeiting protection, a method for imprinting pharmaceutical unit compositions comprising: providing a pharmaceutical unit composition, partially coating the exterior of the...
US20130202700 RAPIDLY DISINTEGRATING COATED TABLETS  
Coated dosage forms comprising a tablet core, preferably in compressed form, that has a coating over its exterior surface and one or more patterns debossed in the tablet surface are disclosed....
US20110020447 NOVEL DOSAGE FORM  
The present invention relates to a novel dosage form, to a process for preparing the dosage form and to the use of the dosage form in the treatment of neurological and psychiatric disorders.
US20110171302 METHOD FOR TREATING NEURODEGENERATIVE DISORDERS WITH ORAL DOSAGE FORMULATION CONTAINING BOTH IMMEDIATE-RELEASE AND SUSTAINED-RELEASE DRUGS  
Disclosed herein is a method for treating patient suffering from a disorder related to central nervous system with an oral dosage formulation that contains both sustained-release and...
US20110300208 SEGMENTED PHARMACEUTICAL DOSAGE FORMS  
A pharmaceutical tablet adapted for accurate division of a dose of a drug into two or more smaller doses, which tablet has two or more segments.
US20140227351 TASTE MASKED PHARMACEUTICAL COMPOSITION  
Taste masked multi-layered particles include an inert core, one or more coating layer(s) comprising a pharmaceutically active ingredient and a binder, an intermediate coating layer (seal coating)...
US20100143467 Pharmaceutical tablets with diffractive microstructure and compression tools for producing such tablets  
A tablet (4) for pharmaceutical use has on at least one part of its surface a diffractive microstructure (11) which generates diffraction effects which can be perceived in the visible spectral...
US20130295176 DIVIDABLE GALENICAL FORM ALLOWING MODIFIED RELEASE OF THE ACTIVE INGREDIENT  
Dividable galenical form for the modified release of active ingredient, wherein the non-subdivided galenical form and a portion of said form obtained by subdivision have identical dissolution...
US20100086591 Rapidly Disintegrating Dosage Form  
The invention provides a rapidly disintegrating dosage form comprising a partially-coated tablet having at least one elongated groove along its surface, such that a portion of the at least one...
US20080003285 Immediate Release Pharmaceutical Tablets With Height Greater Than Width  
An immediate release compressed pharmaceutical tablet that has two or more segments and a top and a bottom and has a height that exceeds the width of the tablet. The height is measured vertically...
US20080241239 Pharmaceutical Tablets Having a Separation Mark Positioned on the Side of Said Tablets  
A pharmaceutical tablet having two segments, one of which is a top segment and the other of which is a bottom segment, said tablet having at least one side wherein said tablet is provided with a...
US20090017115 REMOVAL OF MATERIAL FROM A PREFORMED TABLET  
A system and method of removing material from pharmaceutical tablets, utilizing mechanical or laser energy and a conveyance, to produce a score or other defect in said tablet.
US20070269417 Nicotine delivery systems  
A delivery system for nicotine including nicotine encapsulated in a microcapsule system which releases the encapsulated nicotine on contact of the microencapsules with a nicotine solvent.
US20120177735 ORAL DOSAGE FORMULATION CONTAINING BOTH IMMEDIATE-RELEASE AND SUSTAINED-RELEASE DRUGS FOR TREATING NEURODEGENERATIVE DISORDERS  
Disclosed herein is an oral dosage formulation that contains both immediate-release and sustained release drugs for treating neurodegenerative disorders. The immediate-release drug in the oral...
US20100074949 Pharmaceutical composition and administration thereof  
The present invention relates to pharmaceutical compositions comprising a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4 -oxoquinoline-3-carboxamide, methods of...
US20070237815 DOSAGE FORMS AND METHODS COMPRISING AMLODIPINE AND CHLORTHALIDONE  
The subject invention provides compositions and methods of use of a single dosage form which includes therapeutic or subtherapeutic doses of a dihydropyridine calcium channel blocker (CCB), such...
US20100239668 SEGMENTED PHARMACEUTICAL DOSAGE FORMS  
Described is a layered or segmented controlled release pharmaceutical tablet adapted for separating one segment from another by breaking through a segment.
US20090238870 Dividable galenical form allowing modified release of the active ingredient  
Dividable galenical form for the modified release of active ingredient, wherein the non-subdivided galenical form and a portion of said form obtained by subdivision have identical dissolution...
US20110033537 Sustained Drug Release Composition  
The invention relates to a sustained release formulation for delivering one or more pharmaceutically active agents. The formulation comprises cross-linked high amylose starch and at least one...
US20100255082 Functionally Coated Breakable Tablets  
Tablet and capsule formulations with a similar in vitro drug release profile for whole tablet and when broken and/or a bioequivalent drug release profile when taken whole or when broken are...
US20080233189 Pharmaceutical Tablets Comprising Two or More Unitary Segments  
Accurate means of dosing with a compressed, segmented pharmaceutical tablet, and tablettes formed from said tablets, is disclosed.
US20090110726 FORMULATION HAVING ACCURATE DOSE-DIVIDING FUNCTION  
The present invention provides a tablet comprising a plurality of drug-containing parts and at least one connecting part adhered to the drug-containing parts, and having a scored line capable of...
US20140112988 Pharmaceutical Composition and Administrations Thereof  
The present invention relates to pharmaceutical compositions comprising a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4 -oxoquinoline-3-carboxamide, methods of...
US20090324715 HIGH DOSE ORAL PHARMACEUTICAL COMPOSITIONS OF ARTEMETHER AND LUMEFANTRINE  
The present invention relates to high dose oral pharmaceutical compositions of artemether and lumefantrine, and process for preparation thereof. The compositions comprise of artemether and...
US20150132379 DRY-COATED TABLET  
A dry-coated tablet 1 comprises an inner core 2 which contains an active component and an outer layer 3 which contains powdery solid components and coats the inner core 2. Openings 8c and 9c are...
US20140023708 LAMINATED TABLET AND MANUFACTURING METHOD THEREFOR  
According to the present invention, a multilayer tablet showing suppressed layer separation and a production method thereof are provided. A concave portion having a depth of not less than 0.1 mm...
US20080075772 PHARMACEUTICAL COMPOSITIONS HAVING NOVEL SCORING PATTERNS AND METHODS OF USING THOSE COMPOSITIONS  
The invention provides novel scoring patterns for a wide variety of tablets that contain specific drugs or contain drugs in certain drug classes, and methods of treatment with layered tablets and...
US20080199521 Scored Pharmaceutical Tablets Comprising A Plurality Of Secments  
Deeply scored pharmaceutical tablets are disclosed, along with pharmaceutical tablets with a score in a segment that adjoins a segment lacking a pharmacologically effective dose of any drug.
US20080213362 COMPOSITIONS AND METHODS USING TORSEMIDE  
Dosage forms containing torsemide as the active ingredient, preferably provided at a relatively low dose or strength, are disclosed. The dosage forms can, be formulated as a tablet having a novel...
US20100226980 NOVEL TABLET BASED ON S-ADENOSYL-METHIONINE  
A subject of the invention is a tablet for pharmaceutical use, particularly for veterinary use, particularly suitable for the chronic treatment of hepatic insufficiency, comprising at least one...
US20120294941 PHARMACEUTICAL COMPOSITION WITH ANTI-OBESITY ACTIVITY COMPRISING A PREMIXTURE OF PURE ORLISTAT AND PREPARATION PROCESS  
Pharmaceutical compositions with anti-obesity activity that act peripherally are provided, which comprise a premixture made up of pure orlistat as the active ingredient and other components that...
US20090041843 PHARMACEUTICAL PREPARATION HAVING EXCELLENT PHOTOSTABILITY  
The present invention relates to a pharmaceutical preparation of high photostability which contains pitavastatin, which is an HMG-CoA reductase inhibitor, a salt of pitavastatin, or an ester of...
US20080233190 Segmented Pharmaceutical Dosage Forms  
A pharmaceutical tablet adapted for accurate division of a dose of a drug into two or more smaller doses, which tablet has two or more segments.
US20080063709 PHARMACEUTICAL COMPOSITIONS HAVING NOVEL SCORING PATTERNS  
The invention provides novel scoring patterns for a wide variety of tablets that contain specific drugs or contain drugs in certain drug classes, preferably doxepin.

Matches 1 - 34 out of 34